Management of Device Detected AT and Impact of Device Treatment Algorithms on Atrial Fibrillation

Exclusion criteria

• ✕. Subject has been implanted with a Medtronic cardiac implantable device with an atrial lead equipped with atrial ATP therapies (rATP) enabled for more than 18 months;
• ✕. Subject is in permanent AF or persistent AF at the baseline visit:
• ✕. The definition of permanent AF will be based on the physicians' decision that nothing further can be done to cardiovert the patient or, in historical cases, the investigators will refer to the Cardiac Compass reports:
• ✕. The definition of persistent AF at baseline will refer to the Cardiac Compass reports (\>7 consecutive days in AF with the last day being the day of enrollment)
• ✕. Participation in other studies which could potentially conflict with this study;
• ✕. Legal incapacity or evidence that a subject cannot understand the purpose and risks of the study or inability to comply fully with study procedures and follow up.